McGuire Capital Advisors’s Edesa Biotech EDSA Stock Holding History

McGuire Capital Advisors’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2K	Hold	1,500	–	–	0.01%	401
2026 Q1	$7.84K	Buy	+1,500	New	+$4.5K	0.01%	440

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

McGuire Capital Advisors's EDSA Position: Q2 2026 in Review

McGuire Capital Advisors held its Edesa Biotech (EDSA) position steady in Q2 2026 at 1,500 shares worth $12.2K. The position accounts for 0.01% of the portfolio, ranked #401.

McGuire Capital Advisors first reported a position in EDSA in Q1 2026 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

McGuire Capital Advisors held 1,500 shares of Edesa Biotech worth $12.2K as of Q2 2026.
McGuire Capital Advisors left its Edesa Biotech share count unchanged in Q2 2026.
Edesa Biotech made up 0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #401 holding.
McGuire Capital Advisors first reported a position in Edesa Biotech in Q1 2026 and has held it in 2 quarters since.
30 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.